Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel–cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines

References

• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• DeSantisCEFedewaSASauerAGKramerJLSmithRAJemalABreast cancer statistics, 2015: convergence of incidence rates between black and white womenCA Cancer J Clin2016661314226513636
   PubMed Web of Science ®Google Scholar
• FoulkesWDSmithIEReis-FilhoJSTriple-negative breast cancerN Engl J Med2010363201938194821067385
   PubMed Web of Science ®Google Scholar
• BauerKRBrownMCressRDPariseCACaggianoVDescriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer RegistryCancer200710991721172817387718
   PubMed Web of Science ®Google Scholar
• LiedtkeCMazouniCHessKRResponse to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancerJ Clin Oncol20082681275128118250347
   PubMed Web of Science ®Google Scholar
• De LaurentiisMCiannielloDCaputoRTreatment of triple negative breast cancer (TNBC): current options and future perspectivesCancer Treat Rev201036Suppl 3S80S8621129616
   PubMed Web of Science ®Google Scholar
• CareyLADeesECSawyerLThe triple negative paradox: primary tumor chemosensitivity of breast cancer subtypesClin Cancer Res20071382329233417438091
   PubMed Web of Science ®Google Scholar
• IsakoffSJTriple negative breast cancer: role of specific chemotherapy agentsCancer J2010161536120164691
   PubMed Web of Science ®Google Scholar
• KassamFEnrightKDentRSurvival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial designClin Breast Cancer200991293319299237
   PubMed Web of Science ®Google Scholar
• MayerIAAbramsonVGLehmannBDPietenpolJANew strategies for triple-negative breast cancer: deciphering the heterogeneityClin Cancer Res201420478279024536073
   PubMed Web of Science ®Google Scholar
• NikanjamMBlakelyEABjornstadKAShuXBudingerTFForteTMSynthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiformeInt J Pharm20073281869416959446
   PubMedGoogle Scholar
• StranzlASchmidtHWinklerRKostnerGMLow-density lipoprotein receptor mRNA in human breast cancer cells: influence by PKC modulatorsBreast Cancer Res Treat19974231952059065603
   PubMed Web of Science ®Google Scholar
• ZhangBSunXMeiHLDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain gliomaBiomaterials201334369171918224008043
   PubMed Web of Science ®Google Scholar
• RothenederMKostnerGMEffects of low- and high-density lipoproteins on the proliferation of human breast cancer cells in vitro: differences between hormone-dependent and hormone-independent cell linesInt J Cancer19894358758792714893
   PubMed Web of Science ®Google Scholar
• AntalisCJArnoldTRasoolTLeeBBuhmanKKSiddiquiRAHigh ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferationBreast Cancer Res Treat2010122366167019851860
   PubMed Web of Science ®Google Scholar
• AntalisCJUchidaABuhmanKKSiddiquiRAMigration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterificationClin Exp Metastasis201128873374121744083
   PubMed Web of Science ®Google Scholar
• KimJHKimYBaeKHParkTGLeeJHParkKTumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticlesMol Pharm20151241230124125686010
   PubMedGoogle Scholar
• ReynoldsLMulikRSWenXDilipACorbinIRLow-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cellsNanomedicine (Lond)20149142123214124397600
   PubMed Web of Science ®Google Scholar
• JainAJainKKesharwaniPJainNKLow density lipoproteins mediated nanoplatforms for cancer targetingJ Nanopart Res20131591888
   Web of Science ®Google Scholar
• LeeJYKimJHBaeKHLow-density lipoprotein-mimicking nanoparticles for tumor-targeted theranostic applicationsSmall201511222223125137631
   PubMed Web of Science ®Google Scholar
• RodriguesDGCovolanCCCoradiSTBarbozaRMaranhaoRCUse of a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxelJ Pharm Pharmacol200254676577212078992
   PubMed Web of Science ®Google Scholar
• RodriguesDGMariaDAFernandesDCImprovement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studiesCancer Chemother Pharmacol200555656557615726368
   PubMed Web of Science ®Google Scholar
• PiresLAHeggRValdugaCJGrazianiSRRodriguesDGMaranhãoRCUse of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical studyCancer Chemother Pharmacol200963228128718365196
   PubMed Web of Science ®Google Scholar
• TeixeiraRSValdugaCJBenvenuttiLASchreierSMaranhãoRCDelivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptorsJ Pharm Pharmacol200860101287129518812021
   PubMed Web of Science ®Google Scholar
• KretzerIFMariaDAGuidoMCContenteTCMaranhaoRCSimvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing miceInt J Nanomedicine20161188590427022257
   PubMed Web of Science ®Google Scholar
• XiaXJGuoRFLiuYLFormulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complexChem Pharm Bull (Tokyo)201159332132621372412
   PubMed Web of Science ®Google Scholar
• YeJLiuYXiaXImproved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumorsOncol Rep201636139940927175803
   PubMed Web of Science ®Google Scholar
• NagelkerkeABussinkJSweepFCSpanPNGeneration of multicellular tumor spheroids of breast cancer cells: how to go three-dimensionalAnal Biochem20134371171923435308
   PubMed Web of Science ®Google Scholar
• TaharaKSakaiTYamamotoHTakeuchiHHirashimaNKawashimaYImproved cellular uptake of chitosan-modified PLGA nanospheres by A549 cellsInt J Pharm20093821–219820419646519
   PubMed Web of Science ®Google Scholar
• ChiuYLHoYCChenYMThe characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosanJ Control Release2010146115215920580915
   PubMed Web of Science ®Google Scholar
• ZhuQLZhouYGuanMLow-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapyBiomaterials201435225965597624768047
   PubMed Web of Science ®Google Scholar
• HuangHCruzWChenJZhengGLearning from biology: synthetic lipoproteins for drug deliveryWiley Interdiscip Rev Nanomed Nanobiotechnol20157329831425346461
   PubMed Web of Science ®Google Scholar
• MengFAsgharSXuYDesign and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targetingInt J Pharm20165061–2465627094357
   PubMed Web of Science ®Google Scholar
• NikanjamMGibbsARHuntCABudingerTFForteTMSynthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiformeJ Control Release2007124316317117964677
   PubMed Web of Science ®Google Scholar
• EmamiJRezazadehMVarshosazJFormulation of LDL targeted nanostructured lipid carriers loaded with paclitaxel: a detailed study of preparation, freeze drying condition, and in vitro cytotoxicityJ Nanomater20122012358782
   Web of Science ®Google Scholar
• KretzerIFMariaDAMaranhãoRCDrug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsionCell Oncol (Dordr)201235645146023055341
   PubMed Web of Science ®Google Scholar
• ZelenkoZLeRoithDAntoniouIMRajanLGallagherEJSilencing the LDLR in breast cancer cells leads to decreased growth of tumor xenografts in a mouse model of hyperlipidemiaPoster presented at: 2016 Endocrine Society Annual MeetingApril 1–4, 2016Boston, MA
   Google Scholar
• LeiHHofferberthSCLiuRPaclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroidsJ Thorac Cardiovasc Surg201514951417142525841659
   PubMed Web of Science ®Google Scholar
• XinHShaXJiangXZhangWChenLFangXAnti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticlesBiomaterials201233328167817622889488
   PubMed Web of Science ®Google Scholar
• IvaturiSWootenCJNguyenMDNessGCLopezDDistribution of the LDL receptor within clathrin-coated pits and caveolae in rat and human liverBiochem Biophys Res Commun2014445242242724530906
   PubMed Web of Science ®Google Scholar
• XuSOlenyukBZOkamotoCTHamm-AlvarezSFTargeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advancesAdv Drug Deliv Rev201365112113823026636
   PubMed Web of Science ®Google Scholar